A Multi-objective Multi-type Facility Location Problem for the Delivery of Personalised Medicine
暂无分享,去创建一个
Manuel López-Ibáñez | Richard Allmendinger | Andreea Avramescu | R. Allmendinger | Andreea Avramescu | Manuel López-Ibáñez
[1] Lili Yang,et al. A fuzzy multi-objective programming for optimization of fire station locations through genetic algorithms , 2007, Eur. J. Oper. Res..
[2] Amir Ahmadi-Javid,et al. A survey of healthcare facility location , 2017, Comput. Oper. Res..
[3] P. Reinke,et al. Overcoming Challenges Facing Advanced Therapies in the EU Market. , 2016, Cell stem cell.
[4] C. Quinn,et al. Estimating the Clinical Pipeline of Cell and Gene Therapies and Their Potential Economic Impact on the US Healthcare System. , 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[5] Kalyanmoy Deb,et al. A fast and elitist multiobjective genetic algorithm: NSGA-II , 2002, IEEE Trans. Evol. Comput..
[6] Nilay Shah,et al. Autologous CAR T-cell therapies supply chain: challenges and opportunities? , 2020, Cancer Gene Therapy.
[7] Iyad Rahwan,et al. A genetic algorithm approach for location-inventory-routing problem with perishable products , 2017 .
[8] Seyyed-Mahdi Hosseini-Motlagh,et al. Economic and social collaborative decision-making on visit interval and service level in a two-echelon pharmaceutical supply chain , 2017 .
[9] Nasrin Asgari,et al. Multiple criteria facility location problems: A survey , 2010 .
[10] M. Toumi,et al. Sipuleucel-T (Provenge®)—Autopsy of an Innovative Paradigm Change in Cancer Treatment: Why a Single-Product Biotech Company Failed to Capitalize on its Breakthrough Invention , 2015, BioDrugs.
[11] T. Burkholder,et al. Developing emergency care systems: a human rights-based approach , 2019, Bulletin of the World Health Organization.
[12] Elisabete Gonçalves. Advanced therapy medicinal products: value judgement and ethical evaluation in health technology assessment , 2020, The European Journal of Health Economics.
[13] Karl F. Doerner,et al. Multi-criteria location planning for public facilities in tsunami-prone coastal areas , 2009, OR Spectr..
[14] Haoran Zhang,et al. Multi-objective site selection optimization of the gas-gathering station using NSGA-II , 2018, Process Safety and Environmental Protection.
[15] C. Wild,et al. Technology forecast: advanced therapies in late clinical research, EMA approval or clinical application via hospital exemption , 2019, Journal of market access & health policy.
[16] S. A. MirHassani,et al. A hybrid Firefly-Genetic Algorithm for the capacitated facility location problem , 2014, Inf. Sci..
[17] Andrés L. Medaglia,et al. Solution methods for the bi-objective (cost-coverage) unconstrained facility location problem with an illustrative example , 2006, Ann. Oper. Res..
[18] M. M. Lotfi,et al. A modified NSGA-II solution for a new multi-objective hub maximal covering problem under uncertain shipments , 2014 .
[19] Andrés L. Medaglia,et al. Hybrid biobjective evolutionary algorithms for the design of a hospital waste management network , 2009, J. Heuristics.
[20] Susmita Bandyopadhyay,et al. Solving conflicting bi-objective facility location problem by NSGA II evolutionary algorithm , 2010 .
[21] Mostafa Setak,et al. Multi-objective reliable hub covering location considering customer convenience using NSGA-II , 2014, Int. J. Syst. Assur. Eng. Manag..
[22] Gary R. Weckman,et al. Applying genetic algorithm to a new location and routing model of hazardous materials , 2015 .
[23] Sumanta Basu,et al. Metaheuristic applications on discrete facility location problems: a survey , 2014, OPSEARCH.
[24] J. V. Moran,et al. Initial sequencing and analysis of the human genome. , 2001, Nature.
[25] Alexey Bersenev,et al. Management of ‘out of specification’ commercial autologous CAR-T cell products , 2018, Cell and Gene Therapy Insights.
[26] A. Sinclair,et al. Cost analysis of vein-to-vein CAR T-cell therapy: automated manufacturing and supply chain , 2020, Cell and Gene Therapy Insights.
[27] M. Sulis,et al. Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study , 2018, Leukemia.